MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) is set to participate in the 13th Alzheimer’s & Parkinson’s Drug Development ...

New research has suggested that losing your sense of smell could be a potential early indicator of Alzheimer's disease.

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter ...

University of Arizona neuroscientists studying the brains of songbirds have found that aging alters the gene expressions that ...

Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...

In the study, which was published in The BMJ, researchers analyzed data from 195 countries and territories using the 2021 ...

Researchers at Nanyang Technological University in Singapore have found a new “energy switch” in immune cells in the brain, ...

Neuroscientists at the University of Arizona have found a link between vocal changes and the aging brain in zebra finch songbirds, which could help lead to earlier diagnoses for disorders such as ...

For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates. Idiopathic REM sleep behavior disorder ...

Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...

Neurodegenerative diseases, including Alzheimer’s and Parkinson’s, are progressive conditions marked by neuronal loss, neuroinflammation, and protein ...

Experts predict Parkinson's diasesae cases will rise 112% from 2021 to 2050. Learn the symptoms of Parkinson's disease.